Yahoo Web Search

Search results

    • Rituximab Tied to Increased Infection Risk in RRMS

      Medscape· 15 hours ago

      The B-cell–depleting treatment rituximab was associated with a twofold increased risk for infection in RRMS, regardless of treatment duration or whether the patient had received other DMTs first.